Group One Trading
IBIO icon

Group One Trading’s iBio IBIO Stock Holding History

Group One Trading’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$812 – 7063
2024
Q1 		$812 Sell
200
-900
-82% -$1.13K ﹤0.01% 6674
2023
Q4 		$1.51K Buy
1,100
+1,045
+1,900% +$4.56K ﹤0.01% 6898
2023
Q3 		$334 Sell
55
-290
-84% -$2.51K ﹤0.01% 7388
2023
Q2 		$4.21K Buy
345
+25
+8% +$472 ﹤0.01% 6795
2023
Q1 		$13.3K Buy
320
+55
+21% +$1.42K ﹤0.01% 5777
2022
Q4 		$2.35K Buy
265
+116
+78% +$3.92K ﹤0.01% 6606
2022
Q3 		$13K Sell
149
-3
-2% -$413 ﹤0.01% 6338
2022
Q2 		$20K Sell
152
-42
-22% -$6.31K ﹤0.01% 6284
2022
Q1 		$42K Sell
194
-173
-47% -$36.2K ﹤0.01% 6234
2021
Q4 		$101K Sell
367
-297
-45% -$113K ﹤0.01% 5710
2021
Q3 		$352K Buy
664
+371
+127% +$231K ﹤0.01% 4581
2021
Q2 		$221K Buy
293
+64
+28% +$46.7K ﹤0.01% 5145
2021
Q1 		$177K Buy
229
+173
+309% +$151K ﹤0.01% 5149
2020
Q4 		$30K Buy
56
+28
+100% +$22.8K ﹤0.01% 5294
2020
Q3 		$29K Buy
+28
New +$40.6K ﹤0.01% 4953

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's IBIO Position: Q2 2025 in Review

Group One Trading sold out of iBio (IBIO) in Q2 2025, closing a stake of 156 shares — an estimated $627 sold.

Group One Trading first reported a position in IBIO in Q3 2020 and held it in 17 quarters. The position peaked at $125K in Q3 2021. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Group One Trading reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 156 iBio shares in Q2 2025, an estimated $627.
  • Group One Trading first reported a position in iBio in Q3 2020 and held it in 17 quarters.
  • Group One Trading's iBio position peaked at $125K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.